ST elevation myocardial infarction guidelines today: A systematic review exploring updated ACC/AHA STEMI guidelines and their applications

American Journal of Therapeutics

Volumn 16, Issue 5, 2009, Pages

  Loomba, Rohit Seth ^a   Arora, Rohit ^b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ACS; Acute coronary syndrome; MI; STEMI

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; NITRATE; PACLITAXEL; PLACEBO; RAPAMYCIN; RECOMBINANT PLASMINOGEN ACTIVATOR; RETEPLASE; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ANTICOAGULANT THERAPY; BARE METAL STENT; BLEEDING; BLOOD CLOT LYSIS; CLINICAL TRIAL; DRUG ELUTING STENT; DRUG FATALITY; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; OXYGEN THERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; ST SEGMENT ELEVATION; STROKE; THROMBOSIS;

HUMANS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; QUALITY OF LIFE; SOCIETIES, MEDICAL; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 70349665410     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31818d40df     Document Type: Review

References (20)

1. Kamalesh M, Subramanian U, Ariana A, et al. Similar decline in post-myocardial infarction mortality among subjects with and without diabetes. Am J Med Sci. 2005; 329:228-233. (Pubitemid 40695449)
2. Canto JG, Rogers WJ, Chandra NC, et al. The association of sex and payer status on management and subsequent survival in acute myocardial infarction. Arch Intern Med. 2002;162:587-593.
3. Antman EM. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006;354:1477.
4. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol. 2008; 51:210-247.
5. Antman EM, Ande DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation. 2004;110:588-636.
6. Morrow DA, Antman EA, Schuhwerk KC, et al. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction. J Am Coll Cardiol. 2002;40:71-77.
7. Boersma E, Deckers JW, Simoons ML, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771-775.
8. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs. hospital-initiated thrombolytic therapy: the myocardial infarction triage and intervention trial. JAMA. 1993;270:1211-1216.
9. Antman EM, Anube DT, Armstrong PW, et al. ACC/ AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. J Am Coll Cardiol. 2004;44:671-719.
10. Jollis JG, Roettig ML, Aluko AD, et al. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA. 2007;298:2371-2380.
11. OASIS-6 Trial Group. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-elevation myocardial infarction. JAMA. 2006;13:1519-1530.
12. Stone GW. Horizons AMI: bivalirudin vs heparin plus GP IIb/IIIa. In: Transcatheter Cardiovascular Therapeutics. Washington, DC; ACC. 2007.
13. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189.
14. COMMIT Collaborative Group. Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction. Lancet. 2005;366:1607-1621.
15. Gershlick AH, et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005;353:2758-2768.
16. Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, et al. Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction. J Am Coll Cardiol. 2007;49:422-430.
17. ASSENT-4 PCI Investigators. Primary versus tenecteplasefacilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction randomised trial. Lancet. 2006;367:569-578.
18. Gibson CM,Murphy SA, Montalescot G, et al. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for STsegment elevation myocardial infarction in the ExTRACTTIMI 25 trial. J Am Coll Cardiol. 2007;49:2238-2246.
19. Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;55:2395-2407.
20. Kastrati A, Dibra A, Spaulding C, et al. Meta-analysis of randomized trials on drug-eluting stents vs bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007;28:2706-2713. (Pubitemid 350139205)